Food and Drug Administration

Center for Drug Evaluation and Research

Endocrinologic and Metabolic Drugs Advisory Committee

Holiday Inn Bethesda

8120 Wisconsin Avenue, Bethesda, MD

July 27, 2001

NDA 21-318, FortéoTM (teriparatide injection, rDNA origin) Eli Lilly and Company

Special Government Employee Consultants

Acting Chair:

Mark E. Molitch, M.D.

Professor of Medicine

Northwestern University Medical School

Center for Endocrinology, Metabolism and Molecular Medicine

303 East Chicago Avenue

Tarry Building., Room 15-731

Chicago, Illinois 60611

 

Robert A. Kreisberg, M.D.

Dean, School of Medicine

University of South Alabama

307 University Boulevard, Rm. 170 CSAB

Mobile, Alabama 36688

 

Risk Management Consultant:

Eric S. Holmboe, M.D., FACP

Yale University School of Medicine

1074 LMP

333 Center Street

New Haven, CT 06510

 

Consumer Representative:

Jody L. Pelosi, F.N.P., Ph.D.

Phoenix Indian Medical Center

4212 North 16th Street

Phoenix, AZ 85016

 

Guest:

Henry G. Bone III, M.D.

Director, Michigan Bone and Mineral Clinic

22201 Moross Road, Suite 260

Detroit, Michigan 48236